The lead drug candidate in FusoGen's pipeline is Sifuvirtide, an HIV fusion inhibitor.
融合素的候选先导药物是西夫韦肽,一种HIV融合抑制剂。
The lead drug candidate in FusoGen's pipeline is Sifuvirtide, an HIV fusion inhibitor. One of the first fusion inhibitor drug against HIV.
扶素生物自主开发的第一个产品:艾滋病病毒膜融合抑制剂——西夫韦肽。
应用推荐